| Lantheus Holdings, Inc | $7.2b | $107.50 | +2.3% | 884.9K | |
| Immunome, Inc. | $2.4b | $22.23 | +0.5% | 540.5K | |
| AbCellera Biologics Inc. Common Shares | $2.4b | $6.48 | +5.0% | 4.1M | |
| Aktis Oncology, Inc. Common stock | $1.8b | $25.47 | -0.3% | 215.7K | |
| Alpha Tau Medical Ltd. Ordinary Shares | $1.1b | $13.70 | +14.0% | 1.1M | |
| Crescent Biopharma, Inc. Common Stock | $496.3m | $14.71 | -2.2% | 283.6K | |
| Perspective Therapeutics, Inc. | $388.9m | $2.95 | +0.3% | 849.7K | |
| Actinium Pharmaceuticals, Inc | $30.7m | $0.94 | +3.6% | 56.1K | |
| PLUS THERAPEUTICS, Inc. Common Stock | $30.1m | $3.69 | -5.1% | 213.4K | |
| American Shared Hospital Services | $10.5m | $1.43 | -2.7% | 7.4K | |
| iTonic Holdings Ltd Class A Ordinary Shares | $5.1m | $0.28 | -6.8% | 84.5K |